Mark Sugarman
PHARMACIST at JOHNS HOPKINS PHARMAQUIP INC · MD · Healthcare
$185K
Peak Total Compensation
2
Years Tracked
2x
vs. Median Household
Mark Sugarman has appeared in compensation disclosures over 2 years of available data (2017–2018). Total compensation changed from $184,650 to $180,992 - a -2% change.
Peak total compensation of $184,650 equals 2x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2018 | JOHNS HOPKINS PHARMAQUIP INC | PHARMACIST | $167,754 | $13,238 | $180,992 |
| 2017 | JOHNS HOPKINS PHARMAQUIP INC | PHARMACIST | $172,611 | $12,039 | $184,650 |
Peers at JOHNS HOPKINS PHARMAQUIP INC
| Name | Title | Peak Comp. |
|---|---|---|
| Mary G Myers | PRESIDENT/TRUSTEE | $1.0M |
| Daniel B Smith | PRESIDENT/TRUSTEE | $780K |
| Victoria Semanie | FORMER OFFICER | $461K |
| Nathan Thompson | VP, ADMINISTRATIVE SRVCS | $320K |
| Mitra Gavgani | VP, PHARM SRVCS & CLIN OPS | $314K |
| Penny Carey | EXEC DIR HME/RT | $303K |
| Kristopher Rusinko | EXEC DIR PHARMACY | $273K |
| James Van Daniker | VP, FINANCE & TREASURER | $266K |
| Toni Carter-Radden | DIR OF OPERATIONS | $248K |
| Wendy Jackson | PHARMACY OPS COORDINATOR | $229K |
Email Alerts
Get notified about Mark Sugarman
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →